U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06885762) titled 'Efgartigimod for the Treatment of Guillain-Barre Syndrome' on March 13.
Brief Summary: The goal of this clinical trial is to evaluating the efficacy and safety of efgartigimod in the treatment of Guillain-Barre Syndrome and exploring the immunological mechanisms of efgartigimod therapy in Guillain-Barre Syndrome. The main questions it aims to answer are:
Will efgartigimod improve the symptoms of participants? What medical problems do participants have when using efgartigimod?
Participants will:
On day 1 and day 5 of the treatment period, drug A was administered intravenously.
Keep a diary of their symptoms
Study Start Date: Ap...